UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
_______________________________
(Exact name of registrant as specified in its charter)
_______________________________
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
(Address, including Zip Code, of Principal Executive Offices)
Registrant's telephone number, including area code: (011) (
Not Applicable
(Former name or former address, if changed since last report)
_______________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On August 3, 2021, Willis Towers Watson Public Limited Company ("Willis Towers Watson") issued a press release announcing its financial results for the period ended June 30, 2021.
A copy of Willis Towers Watson's press release is attached hereto as an exhibit to this Current Report on Form 8-K and is incorporated by reference herein. A reconciliation between certain non-GAAP financial measures and reported financial results is provided as an attachment to the press release.
Willis Towers Watson also posted a slide presentation to its website, which it may refer to during its conference call to discuss the results. The slide presentation is attached hereto as Exhibit 99.2 and incorporated herein by reference.
The information contained in Item 2.02 and Item 7.01 of this Current Report on Form 8-K (including Exhibits 99.1 and 99.2) is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
(d) Exhibits
| Exhibit No. | Description | |||
| 99.1 | Press release, dated August 3, 2021, announcing the financial results for the period ended June 30, 2021, for Willis Towers Watson Public Limited Company. | |||
| 99.2 | Slide Presentation, supplementing the above press release. | |||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| WILLIS TOWERS WATSON PLC | ||
| (Registrant) | ||
| Date: August 3, 2021 | By: | /s/ Matthew Furman |
| Name: | Matthew Furman | |
| Title: | General Counsel | |
EXHIBIT 99.1
Willis Towers Watson Reports Strong Second Quarter 2021 Earnings
- Total revenue1 increased 8% to $2.3 billion with constant currency growth of 4% and organic growth of 8%
- Diluted Earnings per Share were $1.41 for the quarter, up 96% over prior year
- Adjusted Diluted Earnings per Share were $2.66 for the quarter, up 48% over prior year
- Income from Operations was $260 million or 11.4% of revenue, up 370 basis points over the prior-year quarter
- Adjusted Operating Income was $409 million or 17.9% of revenue, up 390 basis points compared to the prior-year quarter
- Announced 13% increase in the regular quarterly cash dividend from $0.71 per common share to $0.80 per common share
ARLINGTON, Va. and LONDON, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Willis Towers Watson (NASDAQ: WLTW) (the “Company”), a leading global advisory, broking and solutions company, today announced financial results for the second quarter ended June 30, 2021.
“We delivered very strong quarterly financial results, and I am proud of our results for the first half of 2021,” said John Haley, Willis Towers Watson’s chief executive officer. “In the second quarter we delivered broad-based revenue growth, continued margin expansion, and had significant earnings per share growth. I am encouraged by our growth momentum and the improving macroeconomic outlook. Our financial results reflect our talented colleague base, their perseverance, the strength of our client relationships and our compelling value proposition. We are focused on moving forward independently, with confidence in our ability to continue delivering significant value for all of our stakeholders. We are well-positioned to compete vigorously and independently across our businesses around the world and will continue to innovate and adapt to address evolving client needs.”
Second Quarter Company Highlights
Revenue was $2.29 billion for the second quarter of 2021, an increase of 8% (4% increase constant currency and 8% increase organic) as compared to $2.11 billion for the same period in the prior year.
For the first half of 2021, revenue was $4.88 billion, an increase of 6% (3% increase constant currency and 6% increase organic) as compared to $4.58 billion for the same period in the prior year.
Income from operations for the second quarter of 2021 was $260 million, or 11.4% of revenue, an increase of 370 basis points compared to the second quarter of the prior year. Adjusted operating income was $409 million, or 17.9% of revenue, an increase of 390 basis points compared to the second quarter of the prior year. Net income attributable to Willis Towers Watson for the second quarter of 2021 was $184 million, an increase of 96% from $94 million for the prior-year second quarter. For the quarter, diluted earnings per share were $1.41 and adjusted diluted earnings per share were $2.66. Net income attributable to Willis Towers Watson and diluted earnings per share for the second quarter of 2021 included pre-tax $51 million of transaction and integration expenses mostly related to the proposed Aon combination prior to its termination. The U.S. GAAP tax rate for the quarter was 33.8%, and the adjusted income tax rate for the quarter used in calculating adjusted diluted earnings per share was 19.3%.
Income from operations for the first half of 2021 was $712 million, or 14.6% of revenue, an increase of 320 basis points compared to the first half of the prior year. Adjusted operating income was $988 million, or 20.3% of revenue, an increase of 240 basis points compared to the first half of the prior year. Net income attributable to Willis Towers Watson for the first half of 2021 was $917 million, an increase of 130% from $399 million for the same period in the prior year. For the first half of 2021, diluted earnings per share were $7.04 and adjusted diluted earnings per share were $6.30. Net income attributable to Willis Towers Watson and diluted earnings per share for the first half of 2021 included pre-tax $75 million of transaction and integration expenses mostly related to the proposed Aon combination prior to its termination. For the first half of 2021, the U.S. GAAP tax rate was 17.2%, and the adjusted income tax rate used in calculating adjusted diluted earnings per share was 20.0%.
___________________
1 The revenue amounts included in this release are presented on a U.S. GAAP basis except where stated otherwise. The segment discussion is on an organic basis.
Net income for the second quarter of 2021 was $186 million, or 8.1% of revenue, an increase from net income of $102 million, or 4.8% of revenue for the prior-year second quarter. Adjusted EBITDA for the second quarter of 2021 was $557 million, or 24.4% of revenue, an increase from Adjusted EBITDA of $441 million, or 20.9% of revenue.
Net income for the first half of 2021 was $922 million, or 18.9% of revenue, an increase from net income of $415 million, or 9.1% of revenue for the same period in the prior year. Adjusted EBITDA for the first half of 2021 was $1.29 billion, or 26.4% of revenue, an increase from Adjusted EBITDA of $1.12 billion, or 24.5% of revenue.
Cash flows from operating activities for the six months ended June 30, 2021 were $366 million, down 47% compared to $685 million for the prior-year first half. Free cash flow for the six months ended June 30, 2021 was $287 million, down 48% compared to $550 million for the prior-year first half. The decrease in year-over-year free cash flow was due to net legal settlement payments of approximately $185 million for the previously-announced Stanford and Willis/Towers Watson merger settlements, higher incentive compensation and benefit-related items of approximately $249 million. Absent these items, free cash flow on an adjusted basis would have been $721 million or up 31% versus the prior year. During the six months ended June 30, 2021, the Company had no share repurchase activity.
Risks and Uncertainties Related to the COVID-19 Pandemic
The extent to which COVID-19 continues to impact our business and financial position will depend on future developments, which are difficult to predict, including the severity and scope of the COVID-19 pandemic as well as the types of measures imposed by governmental authorities to contain the virus or address its impact and the duration of those actions and measures. During 2020 and through the first half of 2021, the COVID-19 pandemic had a negative impact on revenue growth, particularly in our businesses that are discretionary in nature, but otherwise it generally did not have a material impact on our overall results. We saw an increased demand for these services, which improved revenue growth, in the second quarter of 2021. We believe this positive trend could continue for the remainder of the year but may vary based on further disruptions to the supply chain, workforce availability, vaccination rates and further social-distancing orders in jurisdictions where we do business. In light of the effects on our own business operations and those of our clients, suppliers and other third parties with whom we interact, the Company has regularly considered the impact of COVID-19 on our business, taking into account our business resilience and continuity plans, financial modeling and stress testing of liquidity and financial resources. For additional information on the risks posed by COVID-19, see additional disclosures in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021.
Segment Highlights
Human Capital & Benefits
The Human Capital & Benefits (HCB) segment had revenue of $836 million, an increase of 9% (4% increase constant currency and 5% increase organic) from $767 million in the prior-year second quarter. On an organic basis, Talent and Rewards returned to revenue growth, led by a sharp increase in demand for advisory work from employers navigating the challenging labor market. Retirement revenue increased with growth in Great Britain driven by funding and Guaranteed Minimum Pension (‘GMP’) equalization work while increased consulting projects drove revenue growth in North America. Health and Benefits revenue grew primarily from increased consulting work in North America alongside continued expansion of our local portfolios and global benefits management appointments outside of North America. Technology and Administrative Solutions revenue increased due to new project and client activity in Great Britain. The HCB segment had an operating margin of 23.0%, as compared to 20.9% for the prior-year second quarter.
Corporate Risk & Broking
The Corporate Risk & Broking (CRB) segment had revenue of $788 million, an increase of 12% (8% increase constant currency and 8% increase organic) from $701 million in the prior-year second quarter. North America benefited from gains in connection with settlements and book-of-business sales in the quarter. On an organic basis North America led the segment followed by International, Western Europe and Great Britain with new business generation and strong renewals across several insurance lines, most notably, in FINEX and Construction. The CRB segment had an operating margin of 22.9%, as compared to 19.2% for the prior-year second quarter.
Investment, Risk & Reinsurance
The Investment, Risk & Reinsurance (IRR) segment had revenue of $400 million, a decrease of 3% (7% decrease constant currency and 15% increase organic) from $413 million in the prior-year second quarter. On an organic basis, most lines of business contributed to the growth. Reinsurance growth was driven by new business wins and favorable renewal factors. Advisory-related fees led the revenue growth in both our Investment business and Insurance Consulting and Technology business, which was further aided by increased contingent performance fees. The IRR segment had an operating margin of 33.3%, as compared to 28.7% for the prior-year second quarter.
In September 2020, the Company sold its Max Matthiessen business, and the sale of Miller, its wholesale insurance broking subsidiary, was completed on March 1, 2021 (see additional disclosures in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021).
Benefits Delivery & Administration
The Benefits Delivery & Administration (BDA) segment had revenue of $242 million, an increase of 16% (16% increase constant currency and 14% increase organic) from $209 million in the prior-year second quarter. BDA’s organic revenue increase was led by Individual Marketplace, primarily by TRANZACT, which generated revenue of $116 million in the second quarter with strong growth in Medicare Advantage sales. The BDA segment had an operating margin of negative 4.3%, as compared to negative 4.2% for the prior-year second quarter.
Dividend Increase and Quarterly Dividend
The Board of Directors of Willis Towers Watson approved a 13% increase in its regular quarterly cash dividend from $0.71 per common share to $0.80 per common share. The company’s next dividend is payable on or around October 15, 2021 to shareholders of record at the close of business on September 30, 2021.
Conference Call
The Company will host a live webcast and conference call to discuss the financial results for the second quarter. It will be held on Tuesday, August 3, 2021, beginning at 9:00 a.m. Eastern Time, and can be accessed via the Internet at www.willistowerswatson.com. The replay of the call will be available shortly after the live call for a period of three months. A telephonic replay of the call will also be available for 24 hours at 404-537-3406, conference ID 1985274.
About Willis Towers Watson
Willis Towers Watson (NASDAQ: WLTW) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has more than 46,000 employees and services clients in more than 140 countries. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com.
Willis Towers Watson Non-GAAP Measures
In order to assist readers of our consolidated financial statements in understanding the core operating results that Willis Towers Watson’s management uses to evaluate the business and for financial planning, we present the following non-GAAP measures: (1) Constant Currency Change, (2) Organic Change, (3) Adjusted Operating Income/Margin, (4) Adjusted EBITDA/Margin, (5) Adjusted Net Income, (6) Adjusted Diluted Earnings Per Share, (7) Adjusted Income Before Taxes, (8) Adjusted Income Taxes/Tax Rate and (9) Free Cash Flow.
We believe that these measures are relevant and provide useful information widely used by analysts, investors and other interested parties in our industry to provide a baseline for evaluating and comparing our operating performance, and in the case of free cash flow, our liquidity results.
Within these measures referred to as ‘adjusted’, we adjust for significant items which will not be settled in cash, or which we believe to be items that are not core to our current or future operations. Some of these items may not be applicable for the current quarter, however they are expected to be part of our full-year results. These items include the following:
- Restructuring costs and transaction and integration expenses – Management believes it is appropriate to adjust for restructuring costs and transaction and integration expenses when they relate to a specific significant program with a defined set of activities and costs that are not expected to continue beyond a defined period of time, or significant acquisition-related transaction expenses. We believe the adjustment is necessary to present how the Company is performing, both now and in the future when the incurrence of these costs will have concluded.
- Gains and losses on disposals of operations – Adjustment to remove the gain or loss resulting from disposed operations.
- Pension settlement and curtailment gains and losses – Adjustment to remove significant pension settlement and curtailment gains and losses to better present how the Company is performing.
- Abandonment of long-lived asset – Adjustment to remove the depreciation expense resulting from internally-developed software that was abandoned prior to being placed into service.
- Provisions for significant litigation – We will include provisions for litigation matters which we believe are not representative of our core business operations. These amounts are presented net of insurance recovery receivables.
- Tax effect of statutory rate changes – Relates to the incremental tax expense or benefit from significant statutory income tax rate changes enacted in material jurisdictions in which we operate.
- Tax effect of the Coronavirus Aid, Relief, and Economic Security (‘CARES’) Act – Relates to the incremental tax expense impact, primarily from the Base Erosion and Anti-Abuse Tax (‘BEAT’), generated from electing certain income tax provisions of the CARES Act.
- Tax effects of internal reorganization – Relates to the U.S. income tax expense resulting from the completion of internal reorganizations of the ownership of certain businesses that reduced the investments held by our U.S.-controlled subsidiaries.
We evaluate our revenue on an as reported (U.S. GAAP), constant currency and organic basis. We believe presenting constant currency and organic information provides valuable supplemental information regarding our comparable results, consistent with how we evaluate our performance internally.
We consider Constant Currency Change, Organic Change, Adjusted Operating Income/Margin, Adjusted EBITDA/Margin, Adjusted Net Income, Adjusted Diluted Earnings Per Share, Adjusted Income Before Taxes, Adjusted Income Taxes/Tax Rate and Free Cash Flow to be important financial measures, which are used to internally evaluate and assess our core operations and to benchmark our operating and liquidity results against our competitors. These non-GAAP measures are important in illustrating what our comparable operating and liquidity results would have been had we not incurred transaction-related and non-recurring items. Our non-GAAP measures and their accompanying definitions are presented as follows:
Constant Currency Change – Represents the year-over-year change in revenue excluding the impact of foreign currency fluctuations. To calculate this impact, the prior year local currency results are first translated using the current year monthly average exchange rates. The change is calculated by comparing the prior year revenue, translated at the current year monthly average exchange rates, to the current year as reported revenue, for the same period. We believe constant currency measures provide useful information to investors because they provide transparency to performance by excluding the effects that foreign currency exchange rate fluctuations have on period-over-period comparability given volatility in foreign currency exchange markets.
Organic Change – Excludes the impact of fluctuations in foreign currency exchange rates, as described above and the period-over-period impact of acquisitions and divestitures on current-year revenue. We believe that excluding transaction-related items from our U.S. GAAP financial measures provides useful supplemental information to our investors, and it is important in illustrating what our core operating results would have been had we not included these transaction-related items, since the nature, size and number of these translation-related items can vary from period to period.
Adjusted Operating Income/Margin – Income from operations adjusted for amortization, restructuring costs, transaction and integration expenses and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted operating income margin is calculated by dividing adjusted operating income by revenue. We consider adjusted operating income/margin to be important financial measures, which are used internally to evaluate and assess our core operations and to benchmark our operating results against our competitors.
Adjusted EBITDA/Margin – Net Income adjusted for provision for income taxes, interest expense, depreciation and amortization, restructuring costs, transaction and integration expenses, gains and losses on disposals of operations and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted EBITDA Margin is calculated by dividing adjusted EBITDA by revenue. We consider adjusted EBITDA/margin to be important financial measures, which are used internally to evaluate and assess our core operations, to benchmark our operating results against our competitors and to evaluate and measure our performance-based compensation plans.
Adjusted Net Income – Net Income Attributable to Willis Towers Watson adjusted for amortization, restructuring costs, transaction and integration expenses, gains and losses on disposals of operations and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results and the related tax effect of those adjustments and the tax effects of internal reorganizations. This measure is used solely for the purpose of calculating adjusted diluted earnings per share.
Adjusted Diluted Earnings Per Share – Adjusted Net Income divided by the weighted-average number of shares of common stock, diluted. Adjusted diluted earnings per share is used to internally evaluate and assess our core operations and to benchmark our operating results against our competitors.
Adjusted Income Before Taxes – Income from operations before income taxes adjusted for amortization, restructuring costs, transaction and integration expenses, gains and losses on disposals of operations and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted income before taxes is used solely for the purpose of calculating the adjusted income tax rate.
Adjusted Income Taxes/Tax Rate – Provision for income taxes adjusted for taxes on certain items of amortization, restructuring costs, transaction and integration expenses, gains and losses on disposals of operations, the tax effects of internal reorganizations, and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results, divided by adjusted income before taxes. Adjusted income taxes is used solely for the purpose of calculating the adjusted income tax rate. Management believes that the adjusted income tax rate presents a rate that is more closely aligned to the rate that we would incur if not for the reduction of pre-tax income for the adjusted items and the tax effects of internal reorganizations, which are not core to our current and future operations.
Free Cash Flow – Cash flows from operating activities less cash used to purchase fixed assets and software for internal use. Free Cash Flow is a liquidity measure and is not meant to represent residual cash flow available for discretionary expenditures. Management believes that free cash flow presents the core operating performance and cash-generating capabilities of our business operations.
These non-GAAP measures are not defined in the same manner by all companies and may not be comparable to other similarly titled measures of other companies. Non-GAAP measures should be considered in addition to, and not as a substitute for, the information contained within our condensed consolidated financial statements.
Reconciliations of these measures are included in the accompanying tables with the following exception.
The Company does not reconcile its forward-looking non-GAAP financial measures to the corresponding U.S. GAAP measures, due to variability and difficulty in making accurate forecasts and projections and/or certain information not being ascertainable or accessible; and because not all of the information, such as foreign currency impacts necessary for a quantitative reconciliation of these forward-looking non-GAAP financial measures to the most directly comparable U.S. GAAP financial measure, is available to the Company without unreasonable efforts. For the same reasons, the Company is unable to address the probable significance of the unavailable information. The Company provides non-GAAP financial measures that it believes will be achieved, however it cannot accurately predict all of the components of the adjusted calculations and the U.S. GAAP measures may be materially different than the non-GAAP measures.
Willis Towers Watson Forward-Looking Statements
This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward-looking statements in this document by words such as “may”, “will”, “would”, “expect”, “anticipate”, “believe”, “estimate”, “plan”, “intend”, “continue”, or similar words, expressions or the negative of such terms or other comparable terminology. These statements include, but are not limited to, such things as our outlook, the impact of the COVID-19 pandemic on our business, impact of the termination of the business combination with Aon plc and the divestitures contemplated in connection therewith, future capital expenditures, ongoing working capital efforts, future share repurchases, financial results (including our revenue), the impact of changes to tax laws on our financial results, existing and evolving business strategies and acquisitions and dispositions, demand for our services and competitive strengths, goals, the benefits of new initiatives, growth of our business and operations, our ability to successfully manage ongoing organizational and technology changes, including investments in improving systems and processes, and plans and references to future successes, including our future financial and operating results, plans, objectives, expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of Willis Towers Watson’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. All forward-looking disclosure is speculative by its nature.
There are important risks, uncertainties, events and factors that could cause our actual results or performance to differ materially from those in the forward-looking statements contained herein, including the following: our ability to successfully establish, execute and achieve our global business strategy as it evolves; changes in demand for our services, including any decline in consulting services, defined benefit pension plans or the purchasing of insurance; the risks related to changes in general economic, business and political conditions, including changes in the financial markets and inflation; the risks relating to the adverse impact of the ongoing COVID-19 pandemic on the demand for our products and services, our cash flows and our business operations, including increased demand on our information technology resources and systems and related risks of cybersecurity breaches or incidents; the risks relating to or arising from the termination of the business combination with Aon plc announced in March 2020 and the divestitures contemplated in connection therewith, including, among others, risks relating to the impact of such terminations on relationships, including with suppliers, customers, employees and regulators, risks relating to litigation in connection with the business combination and the impact of the costs of the business combination that will be borne by us, despite the business combination being terminated and the payment of the termination fee; significant competition that we face and the potential for loss of market share and/or profitability; the impact of seasonality and differences in timing of renewals; the failure to protect client data or breaches of information systems or insufficient safeguards against cybersecurity breaches or incidents; the risk of increased liability or new legal claims arising from our new and existing products and services, and expectations, intentions and outcomes relating to outstanding litigation; the risk of substantial negative outcomes on existing litigation or investigation matters; changes in the regulatory environment in which we operate, including, among other risks, the impacts of pending competition law and regulatory investigations; various claims, government inquiries or investigations or the potential for regulatory action; our ability to make divestitures or acquisitions and our ability to integrate or manage such acquired businesses; our ability to successfully hedge against fluctuations in foreign currency rates; our ability to integrate direct-to-consumer sales and marketing solutions with our existing offerings and solutions; our ability to comply with complex and evolving regulations related to data privacy and cyber security; our ability to successfully manage ongoing organizational changes, including investments in improving systems and processes; disasters or business continuity problems; the impact of Brexit; our ability to successfully enhance our billing, collection and other working capital efforts, and thereby increase our free cash flow; the potential impact of the anticipated replacement of the London Interbank Offered Rate (‘LIBOR’); our ability to properly identify and manage conflicts of interest; reputational damage, including from association with third parties; reliance on third-party services; the loss of key employees or a large number of employees; doing business internationally, including the impact of exchange rates; compliance with extensive government regulation; the risk of sanctions imposed by governments, or changes to associated sanction regulations; our ability to effectively apply technology, data and analytics changes for internal operations, maintaining industry standards and meeting client preferences; changes and developments in the insurance industry or the U.S. healthcare system, including those related to Medicare and any policy changes from the new Presidential administration and legislative actions from the current U.S. Congress; the inability to protect the Company’s intellectual property rights, or the potential infringement upon the intellectual property rights of others; fluctuations in our pension assets and liabilities; our capital structure, including indebtedness amounts, the limitations imposed by the covenants in the documents governing such indebtedness and the maintenance of the financial and disclosure controls and procedures of each; our ability to obtain financing on favorable terms or at all; adverse changes in our credit ratings; the impact of recent or potential changes to U.S. or foreign tax laws, including on our effective tax rate, and the enactment of additional, or the revision of existing, state, federal, and/or foreign regulatory and tax laws and regulations and any policy changes from the new Presidential administration and legislative actions from the current U.S. Congress; U.S. federal income tax consequences to U.S. persons owning at least 10% of our shares; changes in accounting principles, estimates or assumptions; fluctuation in revenue against our relatively fixed or higher than expected expenses; the laws of Ireland being different from the laws of the U.S. and potentially affording less protections to the holders of our securities; and our holding company structure potentially preventing us from being able to receive dividends or other distributions in needed amounts from our subsidiaries. The foregoing list of factors is not exhaustive and new factors may emerge from time to time that could also affect actual performance and results. For more information, please see Part I, Item 1A in our Annual Report on Form 10-K, and our subsequent filings with the SEC. Copies are available online at http://www.sec.gov or www.willistowerswatson.com.
Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of these assumptions, and therefore also the forward-looking statements based on these assumptions, could themselves prove to be inaccurate. Given the significant uncertainties inherent in the forward-looking statements included in this document, our inclusion of this information is not a representation or guarantee by us that our objectives and plans will be achieved.
Our forward-looking statements speak only as of the date made, and we will not update these forward-looking statements unless the securities laws require us to do so. With regard to these risks, uncertainties and assumptions, the forward-looking events discussed in this document may not occur, and we caution you against unduly relying on these forward-looking statements.
Contact
INVESTORS
Claudia De La Hoz | Claudia.Delahoz@willistowerswatson.com
WILLIS TOWERS WATSON
Supplemental Segment Information
(In millions of U.S. dollars)
(Unaudited)
| REVENUE | |||||||||||||||||||||||||||||||||
| Components of Revenue Change(i) | |||||||||||||||||||||||||||||||||
| Three Months Ended June 30, | As Reported | Currency | Constant Currency | Acquisitions/ | Organic | ||||||||||||||||||||||||||||
| 2021 | 2020 | % Change | Impact | Change | Divestitures | Change | |||||||||||||||||||||||||||
| Human Capital & Benefits | $ | 836 | $ | 767 | 9 | % | 5 | % | 4 | % | 0 | % | 5 | % | |||||||||||||||||||
| Corporate Risk & Broking | 788 | 701 | 12 | % | 4 | % | 8 | % | 0 | % | 8 | % | |||||||||||||||||||||
| Investment, Risk & Reinsurance | 400 | 413 | (3 | )% | 4 | % | (7 | )% | (23 | )% | 15 | % | |||||||||||||||||||||
| Benefits Delivery & Administration | 242 | 209 | 16 | % | 0 | % | 16 | % | 2 | % | 14 | % | |||||||||||||||||||||
| Segment Revenue | 2,266 | 2,090 | 8 | % | 4 | % | 4 | % | (4 | )% | 9 | % | |||||||||||||||||||||
| Reimbursable expenses and other | 20 | 23 | |||||||||||||||||||||||||||||||
| Revenue | $ | 2,286 | $ | 2,113 | 8 | % | 4 | % | 4 | % | (4 | )% | 8 | % | |||||||||||||||||||
| Components of Revenue Change(i) | |||||||||||||||||||||||||||||||||
| Six Months Ended June 30, | As Reported | Currency | Constant Currency | Acquisitions/ | Organic | ||||||||||||||||||||||||||||
| 2021 | 2020 | % Change | Impact | Change | Divestitures | Change | |||||||||||||||||||||||||||
| Human Capital & Benefits | $ | 1,711 | $ | 1,617 | 6 | % | 4 | % | 2 | % | 0 | % | 2 | % | |||||||||||||||||||
| Corporate Risk & Broking | 1,598 | 1,440 | 11 | % | 4 | % | 7 | % | 0 | % | 6 | % | |||||||||||||||||||||
| Investment, Risk & Reinsurance | 1,005 | 1,028 | (2 | )% | 4 | % | (6 | )% | (14 | )% | 8 | % | |||||||||||||||||||||
| Benefits Delivery & Administration | 529 | 440 | 20 | % | 0 | % | 20 | % | 2 | % | 19 | % | |||||||||||||||||||||
| Segment Revenue | 4,843 | 4,525 | 7 | % | 4 | % | 3 | % | (3 | )% | 6 | % | |||||||||||||||||||||
| Reimbursable expenses and other | 33 | 54 | |||||||||||||||||||||||||||||||
| Revenue | $ | 4,876 | $ | 4,579 | 6 | % | 4 | % | 3 | % | (3 | )% | 6 | % | |||||||||||||||||||
(i) Components of revenue change may not add due to rounding
SEGMENT OPERATING INCOME/(LOSS) (i)
| Three Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Human Capital & Benefits | $ | 192 | $ | 160 | ||||
| Corporate Risk & Broking | 181 | 135 | ||||||
| Investment, Risk & Reinsurance | 133 | 119 | ||||||
| Benefits Delivery & Administration | (10 | ) | (9 | ) | ||||
| Segment Operating Income | $ | 496 | $ | 405 | ||||
| Six Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Human Capital & Benefits | $ | 412 | $ | 373 | ||||
| Corporate Risk & Broking | 343 | 262 | ||||||
| Investment, Risk & Reinsurance | 423 | 396 | ||||||
| Benefits Delivery & Administration | (3 | ) | (20 | ) | ||||
| Segment Operating Income | $ | 1,175 | $ | 1,011 | ||||
(i) Segment operating income/(loss) excludes certain costs, including amortization of intangibles, restructuring costs, transaction and integration expenses, certain litigation provisions, and to the extent that the actual expense based upon which allocations are made differs from the forecast/budget amount, a reconciling item will be created between internally-allocated expenses and the actual expenses reported for U.S. GAAP purposes.
SEGMENT OPERATING MARGINS
| Three Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Human Capital & Benefits | 23.0 | % | 20.9 | % | ||||
| Corporate Risk & Broking | 22.9 | % | 19.2 | % | ||||
| Investment, Risk & Reinsurance | 33.3 | % | 28.7 | % | ||||
| Benefits Delivery & Administration | (4.3 | )% | (4.2 | )% | ||||
| Six Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Human Capital & Benefits | 24.1 | % | 23.1 | % | ||||
| Corporate Risk & Broking | 21.5 | % | 18.2 | % | ||||
| Investment, Risk & Reinsurance | 42.1 | % | 38.5 | % | ||||
| Benefits Delivery & Administration | (0.6 | )% | (4.4 | )% | ||||
RECONCILIATIONS OF SEGMENT OPERATING INCOME TO INCOME FROM OPERATIONS BEFORE INCOME TAXES
| Three Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Segment Operating Income | $ | 496 | $ | 405 | ||||
| Amortization | (98 | ) | (119 | ) | ||||
| Transaction and integration expenses(i) | (51 | ) | (14 | ) | ||||
| Unallocated, net(ii) | (87 | ) | (109 | ) | ||||
| Income from Operations | 260 | 163 | ||||||
| Interest expense | (52 | ) | (62 | ) | ||||
| Other income, net | 74 | 76 | ||||||
| Income from operations before income taxes | $ | 282 | $ | 177 | ||||
| Six Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Segment Operating Income | $ | 1,175 | $ | 1,011 | ||||
| Amortization | (201 | ) | (240 | ) | ||||
| Transaction and integration expenses(i) | (75 | ) | (23 | ) | ||||
| Unallocated, net(ii) | (187 | ) | (225 | ) | ||||
| Income from Operations | 712 | 523 | ||||||
| Interest expense | (111 | ) | (123 | ) | ||||
| Other income, net | 513 | 168 | ||||||
| Income from operations before income taxes | $ | 1,114 | $ | 568 | ||||
(i) Includes mainly transaction costs related to the proposed Aon combination prior to its termination.
(ii) Includes certain costs, primarily related to corporate functions which are not directly related to the segments, and certain differences between budgeted expenses determined at the beginning of the year and actual expenses that we report for U.S. GAAP purposes.
WILLIS TOWERS WATSON
Reconciliations of Non-GAAP Measures
(In millions of U.S. dollars, except per share data)
(Unaudited)
RECONCILIATIONS OF NET INCOME ATTRIBUTABLE TO WILLIS TOWERS WATSON TO ADJUSTED DILUTED EARNINGS PER SHARE
| Three Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Net Income attributable to Willis Towers Watson | $ | 184 | $ | 94 | ||||
| Adjusted for certain items: | ||||||||
| Amortization | 98 | 119 | ||||||
| Transaction and integration expenses | 51 | 14 | ||||||
| Loss on disposal of operations | 2 | 2 | ||||||
| Tax effect on certain items listed above(i) | (28 | ) | (30 | ) | ||||
| Tax effect of statutory rate change | 40 | — | ||||||
| Tax effect of the CARES Act | — | 35 | ||||||
| Adjusted Net Income | $ | 347 | $ | 234 | ||||
| Weighted-average shares of common stock, diluted | 130 | 130 | ||||||
| Diluted Earnings Per Share | $ | 1.41 | $ | 0.72 | ||||
| Adjusted for certain items:(ii) | ||||||||
| Amortization | 0.75 | 0.91 | ||||||
| Transaction and integration expenses | 0.39 | 0.11 | ||||||
| Loss on disposal of operations | 0.02 | 0.02 | ||||||
| Tax effect on certain items listed above(i) | (0.21 | ) | (0.23 | ) | ||||
| Tax effect of statutory rate change | 0.31 | — | ||||||
| Tax effect of the CARES Act | — | 0.27 | ||||||
| Adjusted Diluted Earnings Per Share | $ | 2.66 | $ | 1.80 | ||||
| Six Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Net Income attributable to Willis Towers Watson | $ | 917 | $ | 399 | ||||
| Adjusted for certain items: | ||||||||
| Abandonment of long-lived asset | — | 35 | ||||||
| Amortization | 201 | 240 | ||||||
| Transaction and integration expenses | 75 | 23 | ||||||
| Gain/(loss) on disposal of operations | (357 | ) | 2 | |||||
| Tax effect on certain items listed above(i) | (55 | ) | (65 | ) | ||||
| Tax effect of statutory rate change | 40 | — | ||||||
| Tax effect of the CARES Act | — | 35 | ||||||
| Adjusted Net Income | $ | 821 | $ | 669 | ||||
| Weighted-average shares of common stock, diluted | 130 | 130 | ||||||
| Diluted Earnings Per Share | $ | 7.04 | $ | 3.07 | ||||
| Adjusted for certain items:(ii) | ||||||||
| Abandonment of long-lived asset | — | 0.27 | ||||||
| Amortization | 1.54 | 1.84 | ||||||
| Transaction and integration expenses | 0.58 | 0.18 | ||||||
| Gain/(loss) on disposal of operations | (2.74 | ) | 0.02 | |||||
| Tax effect on certain items listed above(i) | (0.42 | ) | (0.50 | ) | ||||
| Tax effect of statutory rate change | 0.31 | — | ||||||
| Tax effect of the CARES Act | — | 0.27 | ||||||
| Adjusted Diluted Earnings Per Share | $ | 6.30 | $ | 5.14 | ||||
(i) The tax effect was calculated using an effective tax rate for each item.
(ii) Per share values and totals may differ due to rounding.
RECONCILIATIONS OF NET INCOME TO ADJUSTED EBITDA
| Three Months Ended June 30, | ||||||||||||||
| 2021 | 2020 | |||||||||||||
| Net Income | $ | 186 | 8.1 | % | $ | 102 | 4.8 | % | ||||||
| Provision for income taxes | 96 | 75 | ||||||||||||
| Interest expense | 52 | 62 | ||||||||||||
| Depreciation | 72 | 67 | ||||||||||||
| Amortization | 98 | 119 | ||||||||||||
| Transaction and integration expenses | 51 | 14 | ||||||||||||
| Loss on disposal of operations | 2 | 2 | ||||||||||||
| Adjusted EBITDA and Adjusted EBITDA Margin | $ | 557 | 24.4 | % | $ | 441 | 20.9 | % | ||||||
| Six Months Ended June 30, | ||||||||||||||
| 2021 | 2020 | |||||||||||||
| Net Income | $ | 922 | 18.9 | % | $ | 415 | 9.1 | % | ||||||
| Provision for income taxes | 192 | 153 | ||||||||||||
| Interest expense | 111 | 123 | ||||||||||||
| Depreciation(i) | 143 | 165 | ||||||||||||
| Amortization | 201 | 240 | ||||||||||||
| Transaction and integration expenses | 75 | 23 | ||||||||||||
| Gain/(loss) on disposal of operations | (357 | ) | 2 | |||||||||||
| Adjusted EBITDA and Adjusted EBITDA Margin | $ | 1,287 | 26.4 | % | $ | 1,121 | 24.5 | % | ||||||
(i) Includes abandonment of long-lived asset of $35 million for the six months ended June 30, 2020.
RECONCILIATIONS OF INCOME FROM OPERATIONS TO ADJUSTED OPERATING INCOME
| Three Months Ended June 30, | ||||||||||||||
| 2021 | 2020 | |||||||||||||
| Income from operations | $ | 260 | 11.4 | % | $ | 163 | 7.7 | % | ||||||
| Adjusted for certain items: | ||||||||||||||
| Amortization | 98 | 119 | ||||||||||||
| Transaction and integration expenses | 51 | 14 | ||||||||||||
| Adjusted operating income | $ | 409 | 17.9 | % | $ | 296 | 14.0 | % | ||||||
| Six Months Ended June 30, | ||||||||||||||
| 2021 | 2020 | |||||||||||||
| Income from operations | $ | 712 | 14.6 | % | $ | 523 | 11.4 | % | ||||||
| Adjusted for certain items: | ||||||||||||||
| Abandonment of long-lived asset | — | 35 | ||||||||||||
| Amortization | 201 | 240 | ||||||||||||
| Transaction and integration expenses | 75 | 23 | ||||||||||||
| Adjusted operating income | $ | 988 | 20.3 | % | $ | 821 | 17.9 | % | ||||||
RECONCILIATIONS OF GAAP INCOME TAXES/TAX RATE TO ADJUSTED INCOME TAXES/TAX RATE
| Three Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Income from operations before income taxes | $ | 282 | $ | 177 | ||||
| Adjusted for certain items: | ||||||||
| Amortization | 98 | 119 | ||||||
| Transaction and integration expenses | 51 | 14 | ||||||
| Loss on disposal of operations | 2 | 2 | ||||||
| Adjusted income before taxes | $ | 433 | $ | 312 | ||||
| Provision for income taxes | $ | 96 | $ | 75 | ||||
| Tax effect on certain items listed above(i) | 28 | 30 | ||||||
| Tax effect of statutory rate change | (40 | ) | — | |||||
| Tax effect of the CARES Act | — | (35 | ) | |||||
| Adjusted income taxes | $ | 84 | $ | 70 | ||||
| U.S. GAAP tax rate | 33.8 | % | 42.2 | % | ||||
| Adjusted income tax rate | 19.3 | % | 22.2 | % | ||||
| Six Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Income from operations before income taxes | $ | 1,114 | $ | 568 | ||||
| Adjusted for certain items: | ||||||||
| Abandonment of long-lived asset | — | 35 | ||||||
| Amortization | 201 | 240 | ||||||
| Transaction and integration expenses | 75 | 23 | ||||||
| Gain/(loss) on disposal of operations | (357 | ) | 2 | |||||
| Adjusted income before taxes | $ | 1,033 | $ | 868 | ||||
| Provision for income taxes | $ | 192 | $ | 153 | ||||
| Tax effect on certain items listed above(i) | 55 | 65 | ||||||
| Tax effect of statutory rate change | (40 | ) | — | |||||
| Tax effect of the CARES Act | — | (35 | ) | |||||
| Adjusted income taxes | $ | 207 | $ | 183 | ||||
| U.S. GAAP tax rate | 17.2 | % | 26.9 | % | ||||
| Adjusted income tax rate | 20.0 | % | 21.1 | % | ||||
(i) The tax effect was calculated using an effective tax rate for each item.
RECONCILIATION OF CASH FLOWS FROM OPERATING ACTIVITIES TO FREE CASH FLOW
| Six Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| Cash flows from operating activities | $ | 366 | $ | 685 | ||||
| Less: Additions to fixed assets and software for internal use | (79 | ) | (135 | ) | ||||
| Free Cash Flow | $ | 287 | $ | 550 | ||||
WILLIS TOWERS WATSON
Condensed Consolidated Statements of Income
(In millions of U.S. dollars, except per share data)
(Unaudited)
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Revenue | $ | 2,286 | $ | 2,113 | $ | 4,876 | $ | 4,579 | ||||||||
| Costs of providing services | ||||||||||||||||
| Salaries and benefits | 1,407 | 1,363 | 2,930 | 2,757 | ||||||||||||
| Other operating expenses | 398 | 387 | 815 | 871 | ||||||||||||
| Depreciation | 72 | 67 | 143 | 165 | ||||||||||||
| Amortization | 98 | 119 | 201 | 240 | ||||||||||||
| Transaction and integration expenses | 51 | 14 | 75 | 23 | ||||||||||||
| Total costs of providing services | 2,026 | 1,950 | 4,164 | 4,056 | ||||||||||||
| Income from operations | 260 | 163 | 712 | 523 | ||||||||||||
| Interest expense | (52 | ) | (62 | ) | (111 | ) | (123 | ) | ||||||||
| Other income, net | 74 | 76 | 513 | 168 | ||||||||||||
| INCOME FROM OPERATIONS BEFORE INCOME TAXES | 282 | 177 | 1,114 | 568 | ||||||||||||
| Provision for income taxes | (96 | ) | (75 | ) | (192 | ) | (153 | ) | ||||||||
| NET INCOME | 186 | 102 | 922 | 415 | ||||||||||||
| Income attributable to non-controlling interests | (2 | ) | (8 | ) | (5 | ) | (16 | ) | ||||||||
| NET INCOME ATTRIBUTABLE TO WILLIS TOWERS WATSON | $ | 184 | $ | 94 | $ | 917 | $ | 399 | ||||||||
| EARNINGS PER SHARE | ||||||||||||||||
| Basic earnings per share | $ | 1.42 | $ | 0.73 | $ | 7.06 | $ | 3.08 | ||||||||
| Diluted earnings per share | $ | 1.41 | $ | 0.72 | $ | 7.04 | $ | 3.07 | ||||||||
| Weighted-average shares of common stock, basic | 130 | 129 | 130 | 130 | ||||||||||||
| Weighted-average shares of common stock, diluted | 130 | 130 | 130 | 130 | ||||||||||||
WILLIS TOWERS WATSON
Condensed Consolidated Balance Sheets
(In millions of U.S. dollars, except share data)
(Unaudited)
| June 30, | December 31, | |||||||
| 2021 | 2020 | |||||||
| ASSETS | ||||||||
| Cash and cash equivalents | $ | 2,217 | $ | 2,089 | ||||
| Fiduciary assets | 15,379 | 15,160 | ||||||
| Accounts receivable, net | 2,507 | 2,555 | ||||||
| Prepaid and other current assets | 465 | 497 | ||||||
| Total current assets | 20,568 | 20,301 | ||||||
| Fixed assets, net | 927 | 1,014 | ||||||
| Goodwill | 10,995 | 11,204 | ||||||
| Other intangible assets, net | 2,786 | 3,043 | ||||||
| Right-of-use assets | 830 | 902 | ||||||
| Pension benefits assets | 1,026 | 971 | ||||||
| Other non-current assets | 1,135 | 1,096 | ||||||
| Total non-current assets | 17,699 | 18,230 | ||||||
| TOTAL ASSETS | $ | 38,267 | $ | 38,531 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Fiduciary liabilities | $ | 15,379 | $ | 15,160 | ||||
| Deferred revenue and accrued expenses | 1,782 | 2,161 | ||||||
| Current debt | 1,110 | 971 | ||||||
| Current lease liabilities | 152 | 152 | ||||||
| Other current liabilities | 751 | 888 | ||||||
| Total current liabilities | 19,174 | 19,332 | ||||||
| Long-term debt | 3,995 | 4,664 | ||||||
| Liability for pension benefits | 1,238 | 1,405 | ||||||
| Deferred tax liabilities | 628 | 561 | ||||||
| Provision for liabilities | 399 | 407 | ||||||
| Long-term lease liabilities | 838 | 918 | ||||||
| Other non-current liabilities | 280 | 312 | ||||||
| Total non-current liabilities | 7,378 | 8,267 | ||||||
| TOTAL LIABILITIES | 26,552 | 27,599 | ||||||
| COMMITMENTS AND CONTINGENCIES | ||||||||
| EQUITY(i) | ||||||||
| Additional paid-in capital | 10,785 | 10,748 | ||||||
| Retained earnings | 3,166 | 2,434 | ||||||
| Accumulated other comprehensive loss, net of tax | (2,278 | ) | (2,359 | ) | ||||
| Treasury shares, at cost, 17,519 shares in 2021 and 2020 | (3 | ) | (3 | ) | ||||
| Total Willis Towers Watson shareholders' equity | 11,670 | 10,820 | ||||||
| Non-controlling interests | 45 | 112 | ||||||
| Total Equity | 11,715 | 10,932 | ||||||
| TOTAL LIABILITIES AND EQUITY | $ | 38,267 | $ | 38,531 | ||||
____________
(i) Equity includes (a) Ordinary shares $0.000304635 nominal value; Authorized 1,510,003,775; Issued 128,987,616 (2021) and 128,964,579 (2020); Outstanding 128,987,616 (2021) and 128,964,579 (2020) and (b) Preference shares, $0.000115 nominal value; Authorized 1,000,000,000 and Issued none in 2021 and 2020.
WILLIS TOWERS WATSON
Condensed Consolidated Statements of Cash Flows
(In millions of U.S. dollars)
(Unaudited)
| Six Months Ended June 30, | ||||||||
| 2021 | 2020 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| NET INCOME | $ | 922 | $ | 415 | ||||
| Adjustments to reconcile net income to total net cash from operating activities: | ||||||||
| Depreciation | 143 | 165 | ||||||
| Amortization | 201 | 240 | ||||||
| Non-cash lease expense | 73 | 74 | ||||||
| Net periodic benefit of defined benefit pension plans | (81 | ) | (92 | ) | ||||
| Provision for doubtful receivables from clients | 8 | 28 | ||||||
| Provision for deferred income taxes | 56 | 40 | ||||||
| Share-based compensation | 52 | 28 | ||||||
| Net (gain)/loss on disposal of operations | (357 | ) | 2 | |||||
| Non-cash foreign exchange gain | (4 | ) | (12 | ) | ||||
| Other, net | (12 | ) | 1 | |||||
| Changes in operating assets and liabilities, net of effects from purchase of subsidiaries: | ||||||||
| Accounts receivable | (39 | ) | 128 | |||||
| Fiduciary assets | (1,198 | ) | (3,200 | ) | ||||
| Fiduciary liabilities | 1,198 | 3,200 | ||||||
| Other assets | (91 | ) | 82 | |||||
| Other liabilities | (506 | ) | (417 | ) | ||||
| Provisions | 1 | 3 | ||||||
| Net cash from operating activities | 366 | 685 | ||||||
| CASH FLOWS FROM/(USED IN) INVESTING ACTIVITIES | ||||||||
| Additions to fixed assets and software for internal use | (79 | ) | (135 | ) | ||||
| Capitalized software costs | (27 | ) | (33 | ) | ||||
| Acquisitions of operations, net of cash acquired | — | (66 | ) | |||||
| Net proceeds from sale of operations | 696 | 2 | ||||||
| Other, net | — | (17 | ) | |||||
| Net cash from/(used in) investing activities | 590 | (249 | ) | |||||
| CASH FLOWS USED IN FINANCING ACTIVITIES | ||||||||
| Senior notes issued | — | 282 | ||||||
| Debt issuance costs | — | (2 | ) | |||||
| Repayments of debt | (515 | ) | (311 | ) | ||||
| Proceeds from issuance of shares | 2 | 5 | ||||||
| Payments of deferred and contingent consideration related to acquisitions | (17 | ) | — | |||||
| Cash paid for employee taxes on withholding shares | (1 | ) | (1 | ) | ||||
| Dividends paid | (269 | ) | (171 | ) | ||||
| Acquisitions of and dividends paid to non-controlling interests | (21 | ) | (14 | ) | ||||
| Other, net | — | (3 | ) | |||||
| Net cash used in financing activities | (821 | ) | (215 | ) | ||||
| INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | 135 | 221 | ||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (10 | ) | (22 | ) | ||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD (i) | 2,096 | 895 | ||||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD (i) | $ | 2,221 | $ | 1,094 | ||||
____________
(i) As a result of the acquired TRANZACT collateralized facility, cash, cash equivalents and restricted cash included $4 million and $7 million of restricted cash at June 30, 2021 and December 31, 2020, respectively, which is included within prepaid and other current assets on our condensed consolidated balance sheets. There was $7 million and $8 million of restricted cash held at June 30, 2020 and December 31, 2019, respectively.
EXHIBIT 99.2
willistowerswatson.com willistowerswatson.com Willis Towers Watson Earnings Release Supplemental Materials 2021 Second Quarter Financial Results August 3, 2021 © 2021 Willis Towers Watson. All rights reserved.
willistowerswatson.com Willis Towers Watson Forward Looking Statements © 2021 Willis Towers Watson. All rights reserved. This document contains “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward - looking statements in this document by words such as “may”, “will”, “would”, “expect”, “anticipate”, “believe”, “estimate”, “plan”, “intend”, “cont inu e”, or similar words, expressions or the negative of such terms or other comparable terminology. These statements include, but are not limited to, such things as our outlook, the impact of the COVID - 19 pandemic on our business, impact of the termination of the business combination with Aon plc and the divestitures contemplated in connection therewith, future capital expenditures, ongoing work ing capital efforts, future share repurchases, financial results (including our revenue), the impact of changes to tax laws on our financial results, existing and evolving business strategies and acquisiti ons and dispositions, demand for our services and competitive strengths, goals, the benefits of new initiatives, growth of our business and operations, our ability to successfully manage ongoing organizati ona l and technology changes, including investments in improving systems and processes, and plans and references to future successes, including our future financial and operating results, plans, objecti ves , expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of Willis Towers Watson’s management and are subje ct to significant risks and uncertainties. Actual results may differ from those set forth in the forward - looking statements. All forward - looking disclosure is speculative by its nature. There are important risks, uncertainties, events and factors that could cause our actual results or performance to differ mat eri ally from those in the forward - looking statements contained herein, including the following: our ability to successfully establish, execute and achieve our global business strategy as it evolves; changes in demand for our services, including any decline in consulting services, defined benefit pension plans or the purchasing of insurance; the risks related to changes in general economic, business and politica l c onditions, including changes in the financial markets and inflation; the risks relating to the adverse impact of the ongoing COVID - 19 pandemic on the demand for our products and services, our cash flows and our business operations, including increased demand on our information technology resources and systems and related risks of cybersecurity breaches or incidents; the risks relating to or arising from the termination of the business combination with Aon plc announced in March 2020 and the divestitures contemplated in connection therewith, including, among others, risks relating to th e impact of such terminations on relationships, including with suppliers, customers, employees and regulators, risks relating to litigation in connection with the business combination and the impact of the costs of the business combination that will be borne by us, despite the business combination being terminated and the payment of the termination fee; significant competition that we face and the po ten tial for loss of market share and/or profitability; the impact of seasonality and differences in timing of renewals; the failure to protect client data or breaches of information systems or insufficient saf eguards against cybersecurity breaches or incidents; the risk of increased liability or new legal claims arising from our new and existing products and services, and expectations, intentions and outco mes relating to outstanding litigation; the risk of substantial negative outcomes on existing litigation or investigation matters; changes in the regulatory environment in which we operate, including, among oth er risks, the impacts of pending competition law and regulatory investigations; various claims, government inquiries or investigations or the potential for regulatory action; our ability to ma ke divestitures or acquisitions and our ability to integrate or manage such acquired businesses; our ability to successfully hedge against fluctuations in foreign currency rates; our ability to integra te direct - to - consumer sales and marketing solutions with our existing offerings and solutions; our ability to comply with complex and evolving regulations related to data privacy and cyber security; our abilit y t o successfully manage ongoing organizational changes, including investments in improving systems and processes; disasters or business continuity problems; the impact of Brexit; our ability to successfu lly enhance our billing, collection and other working capital efforts, and thereby increase our free cash flow; the potential impact of the anticipated replacement of the London Interbank Offered Rate (‘LIBOR ’); our ability to properly identify and manage conflicts of interest; reputational damage, including from association with third parties; reliance on third - party services; the loss of key employees or a large nu mber of employees; doing business internationally, including the impact of exchange rates; compliance with extensive government regulation; the risk of sanctions imposed by governments, or changes to ass ociated sanction regulations; our ability to effectively apply technology, data and analytics changes for internal operations, maintaining industry standards and meeting client preferences; changes an d d evelopments in the insurance industry or the U.S. healthcare system, including those related to Medicare and any policy changes from the new Presidential administration and legislative actions f rom the current U.S. Congress; the inability to protect the Company’s intellectual property rights, or the potential infringement upon the intellectual property rights of others; fluctuations in our pension assets and liabilities; our capital structure, including indebtedness amounts, the limitations imposed by the covenants in the documents governing such indebtedness and the maintenance of the fin anc ial and disclosure controls and procedures of each; our ability to obtain financing on favorable terms or at all; adverse changes in our credit ratings; the impact of recent or potential chang es to U.S. or foreign tax laws, including on our effective tax rate, and the enactment of additional, or the revision of existing, state, federal, and/or foreign regulatory and tax laws and regulations and any policy changes from the new Presidential administration and legislative actions from the current U.S. Congress; U.S. federal income tax consequences to U.S. persons owning at least 10% of our share s; changes in accounting principles, estimates or assumptions; fluctuation in revenue against our relatively fixed or higher than expected expenses; the laws of Ireland being different from the laws o f t he U.S. and potentially affording less protections to the holders of our securities; and our holding company structure potentially preventing us from being able to receive dividends or other distrib uti ons in needed amounts from our subsidiaries. The foregoing list of factors is not exhaustive and new factors may emerge from time to time that could also affect actual performance and results. For more i nfo rmation, please see Part I, Item 1A in our Annual Report on Form 10 - K, and our subsequent filings with the SEC. Copies are available online at http://www.sec.gov or www.willistowerswatson.com. Although we believe that the assumptions underlying our forward - looking statements are reasonable, any of these assumptions, and therefore also the forward - looking statements based on these assumptions, could themselves prove to be inaccurate. Given the significant uncertainties inherent in the forward - looking statem ents included in this document, our inclusion of this information is not a representation or guarantee by us that our objectives and plans will be achieved. Our forward - looking statements speak only as of the date made, and we will not update these forward - looking statements unless th e securities laws require us to do so. With regard to these risks, uncertainties and assumptions, the forward - looking events discussed in this document may not occur, and we caution you against u nduly relying on these forward - looking statements. 1
willistowerswatson.com Willis Towers Watson Non - GAAP Measures © 2021 Willis Towers Watson. All rights reserved. In order to assist readers of our consolidated financial statements in understanding the core operating results that Willis T owe rs Watson’s management uses to evaluate the business and for financial planning, we present the following non - GAAP measures: (1) Constant Currency Change, (2) Organic Change, (3) Adjusted O perating Income/Margin, (4) Adjusted EBITDA/Margin, (5) Adjusted Net Income, (6) Adjusted Diluted Earnings Per Share, (7) Adjusted Income Before Taxes, (8) Adjusted Income Taxes/Tax Ra te and (9) Free Cash Flow. The Company believes that these measures are relevant and provide useful information widely used by analysts, investors and o the r interested parties in our industry to provide a baseline for evaluating and comparing our operating performance, and in the case of free cash flow, our liquidity results. Reconciliations of these measures are included in the accompanying appendix of these earning release supplemental materials. The Company does not reconcile its forward - looking non - GAAP financial measures to the corresponding U.S. GAAP measures, due to v ariability and difficulty in making accurate forecasts and projections and/or certain information not being ascertainable or accessible; and because not all of the information, such as fo reign currency impacts necessary for a quantitative reconciliation of these forward - looking non - GAAP financial measures to the most directly comparable U.S. GAAP financial measure, is available to t he Company without unreasonable efforts. For the same reasons, the Company is unable to address the probable significance of the unavailable information. The Company provides non - GAA P financial measures that it believes will be achieved, however it cannot accurately predict all of the components of the adjusted calculations and the U.S. GAAP measures may be mat eri ally different than the non - GAAP measures. 2
willistowerswatson.com Q2 2021 GAAP Financial Results Key Figures © 2021 Willis Towers Watson. All rights reserved. 3 $USD million, except EPS and % Three months ended June 30, Six months ended June 30, 2020 2021 2020 2021 Revenue as reported % change $2,113 $2,286 +8% $4,579 $4,876 +6% Income from Operations as reported % change $163 $260 +60% $523 $712 +36% Operating Margin % as reported change, basis points 7.7% 11.4% +370 bps 11.4% 14.6% +320 bps Net Income attributable to Willis Towers Watson as reported % change $94 $184 +96% $399 $917 +130% Diluted EPS as reported % change $0.72 $1.41 +96% $3.07 $7.04 +129% Net Cash From Operating Activities as reported % change $685 $366 - 47%
willistowerswatson.com Q2 2021 Key Figures, Includes Non - GAAP Financial Results Willis Towers Watson reports strong second quarter 2021 earnings © 2021 Willis Towers Watson. All rights reserved. $ 2.3 B Q2 2021 Revenue Total Revenue Broad - Based Organic Growth Constant currency growth of 4% and organic revenue growth of 8% for the quarter This reflects our commitment to our clients and their rapidly evolving needs as they continue to navigate unprecedented business disruptions $ 287 M Free Cash Flow six months ended June 30, 2021 Free Cash Flow 1 - 48 % YTD ‘21 vs. YTD ‘20 Short - term Headwind The decrease in year - over - year free cash flow was due to net legal settlement payments of approximately $185 million for the previously announced Stanford and Willis/Towers Watson merger settlements and higher incentive compensation and benefit - related items of approximately $249 $ 2.66 Q2 2021 Adj. Diluted EPS Adj. Diluted EPS 1 Double - Digit Earnings Growth Delivered strong adjusted diluted EPS growth of 48% Underpinned by robust growth in core operations as well as effective management of non - operating activities 17.9 % Q2 2021 Adj. Operating Margin Adj. Operating Margin 1 Core Margin Expansion +390bps of core margin expansion Strong organic growth coupled with operational efficiency gains and disciplined expense management helped drive margin expansion + 48 % Q2 2021 $ 1.80 Q2 2020 14.0 % Q2 2020 4 $ 550 M YTD 2020 1 Signifies Non - GAAP financial measures. See appendix for Non - GAAP reconciliations. + 390 bps Q2 2021 + 4 % Q2 2021 + 5 % Q2 2020 Constant Currency % + 8 % Q2 2021 0 % Q2 2020 Organic %
willistowerswatson.com Organic Revenue Growth % Organic Growth Across All Segments Our unwavering commitment to our clients and colleagues is key to our growth © 2021 Willis Towers Watson. All rights reserved. 5 HCB had solid organic revenue growth. Talent and Rewards revenue grew due to an increase in demand for advisory work. Retirement revenue grew in Great Britain driven by funding and Guaranteed Minimum Pension (‘GMP’) equalization work. Health and Benefits revenue grew primarily from increased consulting work in North America. Technology and Administrative Solutions revenue increased due to new project and client activity in Great Britain. CRB produced strong organic growth and was led by North America who benefited from gains in connection with settlements and book - of - business sales. Revenue in International, Western Europe, and Great Britain increased due to new business generation and strong renewals across several insurance lines such as FINEX and Construction. IRR had organic revenue across most lines of business. Reinsurance growth was driven by new business wins and favorable renewals . Investments and Insurance Consulting & Technology revenue growth was led by advisory - related fee s. BDA delivered another quarter of strong organic growth and was led by Individual Marketplace, primarily TRANZACT. For the quarter, TRANZACT revenue was $ 116 million with strong growth in Medicare Advantage sales. Q2 2020 Q2 2021 Human Capital & Benefits - 2% 5% Corporate Risk & Broking 4% 8% Investment, Risk & Reinsurance 2% 15% Benefits Delivery & Administration - 3% 14% Willis Towers Watson 0% 8%
willistowerswatson.com Summary of Segment Financial Results Q2 2021 segment results compared to Q2 2020 © 2021 Willis Towers Watson. All rights reserved. 6 1 The Operating Margin percentage is rounded . As reported, $USD million, except % Q2 2020 Q2 2021 Revenue Operating Margin % 1 Revenue Operating Margin % 1 Margin Year - over - year Human Capital & Benefits 767 21% 836 23% +210 bps Corporate Risk & Broking 701 19% 788 23% +370 bps Investment, Risk & Reinsurance 413 29% 400 33% +460 bps Benefits Delivery & Administration 209 - 4% 242 - 4% - 10 bps
willistowerswatson.com Maintaining A Flexible Balance Sheet Position Reinforcing our business fundamentals; safeguarding WTW’s financial strength 7 © 2021 Willis Towers Watson. All rights reserved. A disciplined capital management strategy intended to provide Willis Towers Watson with the financial flexibility to reinvest in our businesses, capitalize on market growth opportunities, and support significant value creation for shareholders Our capital structure provides a solid foundation for business strength and growth in the long - term A solid history of effectively managing our leverage with a commitment to maintaining investment grade credit rating Our disciplined approach to managing outstanding debt has successfully reduced the leverage profile 1 Total Debt equals sum of current debt and long - term debt as shown on the Consolidated Balance Sheets. 2 Signifies Non - GAAP financial measure. See appendix for Non - GAAP reconciliations. $USD million June 30 , 2020 Dec 31 , 2020 June 30, 2021 Cash and Cash Equivalents 1,087 2,089 2,217 Total Debt 1 5,593 5,635 5,105 Total Equity 10,456 10,932 11,715 Debt to Adj. EBITDA 2 Trailing 12 - month 2.3x 2.3x 1.9x
willistowerswatson.com A Capital Strategy Fit For The Short & Long - Term 8 © 2021 Willis Towers Watson. All rights reserved. CASH RETURNED TO SHAREHOLDERS $ 3.6 B FY2016 to Q2 FY2021 $ 306 2017 $ 396 $ 199 2016 $ 602 $ 709 $ 908 $ 277 2018 $ 150 $ 329 2019 $ 346 2020 $ 269 2021 $ 595 $ 986 $ 346 $ 479 $ 269 MEANINGFUL DIVIDEND GROWTH + 11 % Cash dividend growth 5 years CAGR 0.80 $ 0.53 2020 2018 2016 2017 $ 0.71 2019 2021 $ 0.48 $ 0.60 $ 0.65 Dividends Share repurchases Quarterly cash dividend per share +11% $ million Disciplined approach to capital allocation A capital light business model and capital structure allow us to shift capital between growth and value creation based on changes in the businesses and/or the macro environment A strong focus on return on investment to optimize the use of cash A disciplined approach to managing our pipeline of investment opportunities. Matching capital with opportunities that yields the best results for our clients, colleagues, and shareholders Goals to prioritize use of cash 1. Reinvest in our capabilities, businesses, and processes 2. Invest in innovation, technology, and new business opportunities 3. Return excess cash to shareholders through share repurchase 4. Strengthen balance sheet and liquidity 5. Sustain dividends and payout ratio 6. Pursue opportunistic mergers, acquisitions, and divestitures
willistowerswatson.com willistowerswatson.com Appendix: Reconciliation of Non - GAAP Measures 9 © 2021 Willis Towers Watson. All rights reserved.
willistowerswatson.com Appendix 1: Constant currency and organic revenue change As reported, USD millions, except % 10 © 2021 Willis Towers Watson. All rights reserved. ( i ) Components of revenue change may not add due to rounding Components of Revenue Change ( i ) Three Months Ended June 30, As Reported Currency Constant Currency Acquisitions/ Organic 2021 2020 % Change Impact Change Divestitures Change Human Capital & Benefits $ 836 $ 767 9% 5% 4% 0% 5% Corporate Risk & Broking 788 701 12% 4% 8% 0% 8% Investment, Risk & Reinsurance 400 413 (3)% 4% (7)% (23)% 15% Benefits Delivery & Administration 242 209 16% 0% 16% 2% 14% Segment Revenue 2,266 2,090 8% 4% 4% (4)% 9% Reimbursable expenses and other 20 23 Revenue $ 2,286 $ 2,113 8% 4% 4% (4)% 8% Components of Revenue Change ( i ) Six Months Ended June 30, As Reported Currency Constant Currency Acquisitions/ Organic 2021 2020 % Change Impact Change Divestitures Change Human Capital & Benefits $ 1,711 $ 1,617 6% 4% 2% 0% 2% Corporate Risk & Broking 1,598 1,440 11% 4% 7% 0% 6% Investment, Risk & Reinsurance 1,005 1,028 (2)% 4% (6)% (14)% 8% Benefits Delivery & Administration 529 440 20% 0% 20% 2% 19% Segment Revenue 4,843 4,525 7% 4% 3% (3)% 6% Reimbursable expenses and other 33 54 Revenue $ 4,876 $ 4,579 6% 4% 3% (3)% 6%
willistowerswatson.com Appendix 2: Adjusted operating income and margin, adjusted EBITDA and margin, free cash flow As reported, USD millions, except % 11 © 2021 Willis Towers Watson. All rights reserved. Three Months Ended June 30, 2021 2020 Income from operations $ 260 11.4 % $ 163 7.7 % Adjusted for certain items: Amortization 98 119 Transaction and integration expenses 51 14 Adjusted operating income $ 409 17.9 % $ 296 14.0 % Three Months Ended June 30, 2021 2020 Net Income $ 186 8.1 % $ 102 4.8 % Provision for income taxes 96 75 Interest expense 52 62 Depreciation 72 67 Amortization 98 119 Transaction and integration expenses 51 14 Loss on disposal of operations 2 2 Adjusted EBITDA and Adjusted EBITDA Margin $ 557 24.4 % $ 441 20.9 % Six Months Ended June 30, 2021 2020 Cash flows from operating activities $ 366 $ 685 Less: Additions to fixed assets and software for internal use (79) (135) Free Cash Flow $ 287 $ 550 Six Months Ended June 30, 2021 2020 Income from operations $ 712 14.6 % $ 523 11.4 % Adjusted for certain items: Abandonment of long - lived asset — 35 Amortization 201 240 Transaction and integration expenses 75 23 Adjusted operating income $ 988 20.3 % $ 821 17.9 % Six Months Ended June 30, 2021 2020 Net Income $ 922 18.9 % $ 415 9.1 % Provision for income taxes 192 153 Interest expense 111 123 Depreciation 143 165 Amortization 201 240 Transaction and integration expenses 75 23 (Gain)/loss on disposal of operations (357) 2 Adjusted EBITDA and Adjusted EBITDA Margin $ 1,287 26.4 % $ 1,121 24.5 %
willistowerswatson.com Appendix 3: Adjusted net income and adjusted diluted earnings per share As reported, USD millions, except % and EPS 12 © 2021 Willis Towers Watson. All rights reserved. ( i ) The tax effect was calculated using an effective tax rate for each item. (ii) Per share values and totals may differ due to rounding. Three Months Ended June 30, 2021 2020 Net Income attributable to Willis Towers Watson $ 184 $ 94 Adjusted for certain items: Amortization 98 119 Transaction and integration expenses 51 14 Loss on disposal of operations 2 2 Tax effect on certain items listed above ( i ) (28) (30) Tax effect of statutory rate change 40 — Tax effect of the CARES Act — 35 Adjusted Net Income $ 347 $ 234 Weighted - average shares of common stock, diluted 130 130 Diluted Earnings Per Share $ 1.41 $ 0.72 Adjusted for certain items: (ii) Amortization 0.75 0.91 Transaction and integration expenses 0.39 0.11 Loss on disposal of operations 0.02 0.02 Tax effect on certain items listed above ( i ) (0.21) (0.23) Tax effect of statutory rate change 0.31 — Tax effect of the CARES Act — 0.27 Adjusted Diluted Earnings Per Share $ 2.66 $ 1.80 Six Months Ended June 30, 2021 2020 Net Income attributable to Willis Towers Watson $ 917 $ 399 Adjusted for certain items: Abandonment of long - lived asset — 35 Amortization 201 240 Transaction and integration expenses 75 23 (Gain)/loss on disposal of operations (357) 2 Tax effect on certain items listed above ( i ) (55) (65) Tax effect of statutory rate change 40 — Tax effect of the CARES Act — 35 Adjusted Net Income $ 821 $ 669 Weighted - average shares of common stock, diluted 130 130 Diluted Earnings Per Share $ 7.04 $ 3.07 Adjusted for certain items: (ii) Abandonment of long - lived asset — 0.27 Amortization 1.54 1.84 Transaction and integration expenses 0.58 0.18 (Gain)/loss on disposal of operations (2.74) 0.02 Tax effect on certain items listed above ( i ) (0.42) (0.50) Tax effect of statutory rate change 0.31 — Tax effect of the CARES Act — 0.27 Adjusted Diluted Earnings Per Share $ 6.30 $ 5.14
willistowerswatson.com Appendix 4: Adjusted income before taxes and adjusted income tax rate As reported, USD millions, except % and EPS 13 © 2021 Willis Towers Watson. All rights reserved. ( i ) The tax effect was calculated using an effective tax rate for each item. Three Months Ended June 30, 2021 2020 Income from operations before income taxes $ 282 $ 177 Adjusted for certain items: Amortization 98 119 Transaction and integration expenses 51 14 Loss on disposal of operations 2 2 Adjusted income before taxes $ 433 $ 312 Provision for income taxes $ 96 $ 75 Tax effect on certain items listed above ( i ) 28 30 Tax effect of statutory rate change (40) — Tax effect of the CARES Act — (35) Adjusted income taxes $ 84 $ 70 U.S. GAAP tax rate 33.8 % 42.2 % Adjusted income tax rate 19.3 % 22.2 % Six Months Ended June 30, 2021 2020 Income from operations before income taxes $ 1,114 $ 568 Adjusted for certain items: Abandonment of long - lived asset — 35 Amortization 201 240 Transaction and integration expenses 75 23 (Gain)/loss on disposal of operations (357) 2 Adjusted income before taxes $ 1,033 $ 868 Provision for income taxes $ 192 $ 153 Tax effect on certain items listed above ( i ) 55 65 Tax effect of statutory rate change (40) — Tax effect of the CARES Act — (35) Adjusted income taxes $ 207 $ 183 U.S. GAAP tax rate 17.2 % 26.9 % Adjusted income tax rate 20.0 % 21.1 %
willistowerswatson.com About Willis Towers Watson Willis Towers Watson (NASDAQ: WLTW) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has more than 46,000 employees and services clients in more than 140 countries. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com. © 2021 Willis Towers Watson. All rights reserved. 14